Log in | Join Free | china | japan | germany

(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

Request For Quotation
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Suppliers list
Company Name: guoyungurui  
Tel: 18162595016
Email: 3287908757@qq.com
Products Intro: Product Name:Vinflunine Impurity 18
CAS:1510829-43-2
Purity:95%+HPLC Package:10mg;25mg;50mg;100mg;200mg
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Basic information
Product Name:(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide
Synonyms:(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide;Vinflunine Impurity 18
CAS:1510829-43-2
MF:C23H26ClF4N7O2
MW:0
EINECS:
Product Categories:
Mol File:Mol File
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Structure
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Chemical Properties
Safety Information
MSDS Information
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Usage And Synthesis
(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide Preparation Products And Raw materials
Tag:(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide(1510829-43-2) Related Product Information
Vecabrutinib 4-(2,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-m-tolyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3S,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide rel-(3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide [1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3S,3'R,4'S)- 3(2H)-Furanone, 5-[4-[[(acetyloxy)methyl]thio]phenyl]-4-(3-fluorophenyl)-2,2-dimethyl- 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(4-fluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 2,2-dimethyl-5-(4-(methylthio)phenyl)-4-phenylfuran-3(2H)-one (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(3,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one (3R,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide